These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30357519)

  • 21. MDA-9 and GRP78 as potential diagnostic biomarkers for early detection of melanoma metastasis.
    Guan M; Chen X; Ma Y; Tang L; Guan L; Ren X; Yu B; Zhang W; Su B
    Tumour Biol; 2015 Apr; 36(4):2973-82. PubMed ID: 25480418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Signatures of protein expression revealed by secretome analyses of cancer associated fibroblasts and melanoma cell lines.
    Liberato T; Pessotti DS; Fukushima I; Kitano ES; Serrano SMT; Zelanis A
    J Proteomics; 2018 Mar; 174():1-8. PubMed ID: 29275043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A 2015 update on predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance.
    Dietel M; Jöhrens K; Laffert MV; Hummel M; Bläker H; Pfitzner BM; Lehmann A; Denkert C; Darb-Esfahani S; Lenze D; Heppner FL; Koch A; Sers C; Klauschen F; Anagnostopoulos I
    Cancer Gene Ther; 2015 Sep; 22(9):417-30. PubMed ID: 26358176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteogenomic studies on cancer drug resistance: towards biomarker discovery and target identification.
    Fu S; Liu X; Luo M; Xie K; Nice EC; Zhang H; Huang C
    Expert Rev Proteomics; 2017 Apr; 14(4):351-362. PubMed ID: 28276747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The new melanoma markers: MART-1 and Melan-A (the NIH experience).
    Fetsch PA; Marincola FM; Abati A
    Am J Surg Pathol; 1999 May; 23(5):607-10. PubMed ID: 10328095
    [No Abstract]   [Full Text] [Related]  

  • 26. Integrated proteo-genomic approach for early diagnosis and prognosis of cancer.
    Shukla HD; Mahmood J; Vujaskovic Z
    Cancer Lett; 2015 Dec; 369(1):28-36. PubMed ID: 26276717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deciphering lymphoma pathogenesis via state-of-the-art mass spectrometry-based quantitative proteomics.
    Psatha K; Kollipara L; Voutyraki C; Divanach P; Sickmann A; Rassidakis GZ; Drakos E; Aivaliotis M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Mar; 1047():2-14. PubMed ID: 27979587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oncoproteomics: Trials and tribulations.
    Zhou L; Li Q; Wang J; Huang C; Nice EC
    Proteomics Clin Appl; 2016 Apr; 10(4):516-31. PubMed ID: 26518147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A proteomic signature of ovarian cancer tumor fluid identified by highthroughput and verified by targeted proteomics.
    Poersch A; Grassi ML; Carvalho VP; Lanfredi GP; Palma CS; Greene LJ; de Sousa CB; Carrara HHA; Candido Dos Reis FJ; Faça VM
    J Proteomics; 2016 Aug; 145():226-236. PubMed ID: 27222041
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Emerging Role of Proteomics in Precision Medicine: Applications in Neurodegenerative Diseases and Neurotrauma.
    Alaaeddine R; Fayad M; Nehme E; Bahmad HF; Kobeissy F
    Adv Exp Med Biol; 2017; 1007():59-70. PubMed ID: 28840552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The CPTAC Data Portal: A Resource for Cancer Proteomics Research.
    Edwards NJ; Oberti M; Thangudu RR; Cai S; McGarvey PB; Jacob S; Madhavan S; Ketchum KA
    J Proteome Res; 2015 Jun; 14(6):2707-13. PubMed ID: 25873244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heterogeneity in Melanoma.
    Shannan B; Perego M; Somasundaram R; Herlyn M
    Cancer Treat Res; 2016; 167():1-15. PubMed ID: 26601857
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteomic Mass Spectrometry Imaging for Skin Cancer Diagnosis.
    Lazova R; Seeley EH
    Dermatol Clin; 2017 Oct; 35(4):513-519. PubMed ID: 28886807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Germline determinants of clinical outcome of cutaneous melanoma.
    Vogelsang M; Wilson M; Kirchhoff T
    Pigment Cell Melanoma Res; 2016 Jan; 29(1):15-26. PubMed ID: 26342156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The contribution of proteomics to the identification of biomarkers for cutaneous malignant melanoma.
    Bougnoux AC; Solassol J
    Clin Biochem; 2013 Apr; 46(6):518-23. PubMed ID: 23262402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer proteomics: developments in technology, clinical use and commercialization.
    Yeat NC; Lin C; Sager M; Lin J
    Expert Rev Proteomics; 2015 Aug; 12(4):391-405. PubMed ID: 26145529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heterogeneity revealed by integrated genomic analysis uncovers a molecular switch in malignant uveal melanoma.
    de Lange MJ; van Pelt SI; Versluis M; Jordanova ES; Kroes WG; Ruivenkamp C; van der Burg SH; Luyten GP; van Hall T; Jager MJ; van der Velden PA
    Oncotarget; 2015 Nov; 6(35):37824-35. PubMed ID: 26462151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical initiatives linking Japanese and Swedish healthcare resources on cancer studies utilizing Biobank Repositories.
    Nishimura T; Kawamura T; Sugihara Y; Bando Y; Sakamoto S; Nomura M; Ikeda N; Ohira T; Fujimoto J; Tojo H; Hamakubo T; Kodama T; Andersson R; Fehniger TE; Kato H; Marko-Varga G
    Clin Transl Med; 2014 Dec; 3(1):61. PubMed ID: 25635206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conjunctival malignant melanoma in Denmark: epidemiology, treatment and prognosis with special emphasis on tumorigenesis and genetic profile.
    Larsen AC
    Acta Ophthalmol; 2016 May; 94 Thesis 1():1-27. PubMed ID: 27192168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteogenomics approaches for studying cancer biology and their potential in the identification of acute myeloid leukemia biomarkers.
    Hernandez-Valladares M; Vaudel M; Selheim F; Berven F; Bruserud Ø
    Expert Rev Proteomics; 2017 Aug; 14(8):649-663. PubMed ID: 28693350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.